Tumor regressive effects of viscum album preparations. Exploration of immunomodulatory mechanisms

Medicina

Volumn 67, Issue SUPPL. 2, 2007, Pages 85-89

  Elluru, Sriramulu ^a,b,c,d   van Huyen, Jean Paul Duong ^a,b,c,e   Wootla, Bharath ^a,b,c,d   Delignat, Sandrine ^a,b,c   Prost, Fabienne ^a,b,c   Negi, Vir Singh ^f   Kaveri, Srini V ^a,b,c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f Department of Medicine ^*  (India)

Author keywords

Apoptosis; Cytotoxicity; Endothelium; Immune system; Viscum album

Indexed keywords

LECTIN; POLYPHENOL; POLYSACCHARIDE; VISCUM ALBUM EXTRACT;

ALTERNATIVE MEDICINE; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; APPLE; AQUEOUS SOLUTION; B LYMPHOCYTE; CANCER PATIENT; CANCER TRANSPLANTATION; CELL IMMORTALIZATION; CELL TYPE; CYTOTOXICITY; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LYMPHOBLASTOID CELL; MONOCYTE; NONHUMAN; PINE; PLANT GROWTH; QUALITY OF LIFE; REVIEW; T LYMPHOCYTE; TUMOR CELL; TUMOR REGRESSION; TUMOR VASCULARIZATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VISCUM ALBUM;

EID: 34548507250     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Stirpe F, Sandvig K, Olsnes S. et al. Action of viscumin, a toxic lectin from mistletoe, on cells in culture. J Biol Chem 1982; 257: 13271-7.
2. Olsnes S, Stirpe F, Sandvig K, et al. Isolation and characterization of viscumin, a toxic lectin from Viscum album L. (mistletoe). J Biol Chem 1982; 257: 13263-70.
3. Franz H, Ziska P, Kindt A. Isolation and properties of three lectins from mistletoe (Viscum album L). Biochem J 1981; 195: 481-4.
4. Eschenburg S, Krauspenhaar R, Mikhailov A, et al. Primary structure and molecular modeling of mistletoe lectin I from Viscum album. Biochem Biophys Res Commun 1998; 247: 367-72.
5. Ernst E, Schmidt K, Steuer-Vogt MK. Mistletoe for cancer? A systematic review of randomised clinical trials. Int J Cancer 2003; 107: 262-7.
6. Kienle GS, Berrino F, Bussing A, et al. Mistletoe in cancer - a systematic review on controlled clinical trials. Eur J Med Res 2003; 8: 109-19.
7. Mansky PJ. Mistletoe and cancer: controversies and perspectives. Semin Oncol 2002; 29: 589-94.
8. Braun JM, Ko HL, Schierholz JM, et al. Standardized mistletoe extract augments immune response and downregulates local and metastatic tumor growth in murine models. Anticancer Res 2002; 22: 4187-90.
9. Burger AM, Mengs U, Schuler JB, et al. Anticancer activity of an aqueous mistletoe extract (AME) in syngeneic murine tumor models. Anticancer Res 2001; 21: 1965-8.
10. Park WB, Lyu SY, Kim JH, et al. Inhibition of tumor growth and metastasis by Korean mistletoe lectin is associated with apoptosis and antiangiogenesis. Cancer Biother Radiopharm 2001; 16: 439-47.
11. Ribereau-Gayon G, Jung ML, Baudino S, et al. Effects of mistletoe (Viscum album L.) extracts on cultured tumor cells. Experientia 1986; 42: 594-9.
12. Maier G, Fiebig HH. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro. Anticancer Drugs 2002; 13: 373-9.
13. Bantel H, Engels IH, Voelter W, et al. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res 1999; 59: 2083-90.
14. Hostanska K, Hajto T, Weber K, et al. A natural immunity-activating plant lectin, Viscum album agglutinin-I, induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes. Nat Immun 1996; 15: 295-311.
15. Hostanska K, Vuong V, Rocha S, et al. Recombinant mistletoe lectin induces p53-independent apoptosis in tumor cells and cooperates with ionising radiation. Br J Cancer 2003; 88: 1785-92.
16. Lavastre V, Pelletier M, Saller R, et al. Mechanisms involved in spontaneous and Viscum album agglutinin-I-induced human neutrophil apoptosis: Viscum album agglutinin-I accelerates the loss of antiapoptotic Mcl-1 expression and the degradation of cytoskeletal paxillin and vimentin proteins via caspases. J Immunol 2002; 168: 1419-27.
17. Mockel B, Schwarz T, Zinke H, et al. Effects of mistletoe lectin I on human blood cell lines and peripheral blood cells. Cytotoxicity, apoptosis and induction of cytokines. Arzneimittelforschung 1997; 47: 1145-51.
18. Ribereau-Gayon G, Jung ML, Frantz M. et al. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins. Anticancer Drugs 1997; 8 Suppl 1: S3-8.
19. Duong Van Huyen JP, Sooryanarayana Delignat S, et al. Variable sensitivity of lymphoblastoid cells to apoptosis induced by Viscum album Qu FrF, a therapeutic preparation of mistletoe lectin. Chemotherapy 2001; 47: 366-76.
20. Van Huyen JP, Bayry J, Delignat S, et al. Induction of Apoptosis of Endothelial Cells by Viscum album: A Role for Anti-Tumoral Properties of Mistletoe Lectins. Mol Med 2002; 8: 600-06.
21. Gorter RW, Joller P, Stoss M. Cytokine release of a keratinocyte model after incubation with two different Viscum album L extracts. Am J Ther 2003; 10: 40-47.
22. Hajto T, Hostanska K, Frei K, et al. Increased secretion of tumor necrosis factors alpha, interleukin 1, and interleukin 6 by human mononuclear cells exposed to beta-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res 1990; 50: 3322-26.
23. Hajto T, Hostanska K, Weber K, et al. Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo. Nat Immun 1998; 16: 34-46.
24. Hostanska K, Hajto T, Spagnoli GC, et al. A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells. Nat Immun 1995; 14: 295-304.
25. Kovacs E. Serum levels of IL-12 and the production of IFN-gamma, IL-2 and IL-4 by peripheral blood mononuclear cells (PBMC) in cancer patients treated with Viscum album extract. Biomed Pharmacother 2000; 54: 305-10.
26. Ribereau-Gayon G, Dumont S, Muller C, et al. Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes. Cancer Lett 1996; 109: 33-38.
27. Hajto T, Hostanska K, Gabius HJ. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res 1989; 49: 4803-08.
28. Tabiasco J, Pont F, Fournie JJ, et al. Mistletoe viscotoxins increase natural killer cell-mediated cytotoxicity. Eur J Biochem 2002; 269: 2591-600.
29. Yoon TJ, Yoo YC, Kang TB, et al. Antitumor activity of the Korean mistletoe lectin is attributed to activation of macrophages and NK cells. Arch Pharm Res 2003; 26: 861-67.
30. Duong Van Huyen JP, Delignat S, Kazatchkine MD, et al. Comparative study of the sensitivity of lymphoblastoid and transformed monocytic cell lines to cytotoxic effects of viscum album extracts of different origin. Chemotherapy 2003; 49: 298-302.
31. Büssing A. Induction of apoptosis by the mistletoes lectins: A review on the mechanisms of cytotoxicity mediated by Viscum album L. Apoptosis 1996; 1: 25-32.
32. Elsasser-Beile U, Ruhnau T, Freudenberg N, et al. Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model. Cancer 2001; 91: 998-1004.
33. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-95.
34. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
35. Harmsma M, Gromme M, Ummelen M. et al. Differential effects of Viscum album extract IscadorQu on cell cycle progression and apoptosis in cancer cells. Int J Oncol 2004; 25: 1521-29.
36. Lucas R, Holmgren L, Garcia I, et al. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 1998; 92: 4730-41.
37. Thompson WD, Li WW, Maragoudakis M. The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies. J Pathol 2000; 190: 330-37.
38. Folkman J, Browder T, Palmblad J. Angiogenesis research: guidelines for translation to clinical application. Thromb Haemost 2001; 86: 23-33.
39. Keshet E, Ben-Sasson SA. Anticancer drug targets: approaching angiogenesis. J Clin Invest 1999; 104: 1497-1501.
40. Yoon TJ, Yoo YC, Choi OB, et al. Inhibitory effect of Korean mistletoe (Viscum album coloratum) extract on tumor angiogenesis and metastasis of haematogenous and non-haematogenous tumor cells in mice. Cancer Lett 1995; 97: 83-91.